Two hundred and thirteen patients were randomized in a @:@ ratio to receive either s.c. injections of placebo from weeks @ to @ followed by golimumab @ mg from weeks @ to @ ( group @ , n = @ ) or golimumab @ mg from weeks @ to @ ( group @ , n = @ ) , both every @ weeks .